drugset / Trial / NCT04627025
Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.
Timeline
- Start
- 2021-01-26
- Primary completion
- 2024-01-02
- Completion
- 2024-02-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apraglutide | Peptide | — | Subcutaneous |